Waldron Private Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,229
| Closed | -$945K | – | 347 |
|
|
2024
Q4 | $945K | Buy |
10,229
+327
| +3% | +$29.4K | 0.04% | 177 |
|
|
2024
Q3 | $830K | Buy |
9,902
+684
| +7% | +$52.2K | 0.03% | 181 |
|
|
2024
Q2 | $632K | Sell |
9,218
-281
| -3% | -$18.8K | 0.03% | 200 |
|
|
2024
Q1 | $696K | Sell |
9,499
-829
| -8% | -$63.7K | 0.03% | 198 |
|
|
2023
Q4 | $837K | Buy |
10,328
+4
| +0% | +$311 | 0.04% | 173 |
|
|
2023
Q3 | $774K | Sell |
10,324
-2
| -0% | -$154 | 0.04% | 174 |
|
|
2023
Q2 | $796K | Sell |
10,326
-383
| -4% | -$30.5K | 0.04% | 178 |
|
|
2023
Q1 | $889K | Buy |
10,709
+241
| +2% | +$20K | 0.04% | 180 |
|
|
2022
Q4 | $645K | Hold |
10,468
| – | – | 0.04% | 210 |
|
|
2022
Q3 | $645K | Buy |
10,468
+1,042
| +11% | +$65.7K | 0.04% | 210 |
|
|
2022
Q2 | $582K | Buy |
9,426
+477
| +5% | +$29.5K | 0.03% | 227 |
|
|
2022
Q1 | $532K | Buy |
8,949
+233
| +3% | +$14.9K | 0.03% | 250 |
|
|
2021
Q4 | $632K | Sell |
8,716
-104
| -1% | -$7.16K | 0.03% | 232 |
|
|
2021
Q3 | $616K | Buy |
8,820
+3,289
| +59% | +$231K | 0.04% | 200 |
|
|
2021
Q2 | $380K | Sell |
5,531
-4
| -0.1% | -$267 | 0.02% | 238 |
|
|
2021
Q1 | $357K | Sell |
5,535
-21
| -0.4% | -$1.35K | 0.02% | 226 |
|
|
2020
Q4 | $323K | Sell |
5,556
-306
| -5% | -$18.5K | 0.02% | 219 |
|
|
2020
Q3 | $370K | Buy |
5,862
+896
| +18% | +$62.1K | 0.03% | 194 |
|
|
2020
Q2 | $382K | Buy |
4,966
+529
| +12% | +$40.5K | 0.03% | 180 |
|
|
2020
Q1 | $331K | Buy |
4,437
+281
| +7% | +$19.4K | 0.04% | 178 |
|
|
2019
Q4 | $270K | Sell |
4,156
-63
| -1% | -$4.1K | 0.02% | 219 |
|
|
2019
Q3 | $267K | Sell |
4,219
-32
| -0.8% | -$2.09K | 0.03% | 204 |
|
|
2019
Q2 | $287K | Sell |
4,251
-1,567
| -27% | -$103K | 0.03% | 192 |
|
|
2019
Q1 | $378K | Sell |
5,818
-235
| -4% | -$15.6K | 0.04% | 164 |
|
|
2018
Q4 | $378K | Buy |
6,053
+1,681
| +38% | +$117K | 0.05% | 143 |
|
|
2018
Q3 | $337K | Buy |
4,372
+162
| +4% | +$12.2K | 0.07% | 136 |
|
|
2018
Q2 | $298K | Sell |
4,210
-510
| -11% | -$36K | 0.06% | 136 |
|
|
2018
Q1 | $355K | Hold |
4,720
| – | – | 0.08% | 108 |
|
|
2017
Q4 | $338K | Hold |
4,720
| – | – | 0.08% | 111 |
|
|
2017
Q3 | $382K | Hold |
4,720
| – | – | 0.11% | 89 |
|
|
2017
Q2 | $334K | Sell |
4,720
-5,640
| -54% | -$375K | 0.11% | 81 |
|
|
2017
Q1 | $711K | Buy |
10,360
+1,752
| +20% | +$123K | 0.18% | 76 |
|
|
2016
Q4 | $616K | Sell |
8,608
-608
| -7% | -$45.2K | 0.21% | 55 |
|
|
2016
Q3 | $729K | Sell |
9,216
-459
| -5% | -$37.3K | 0.26% | 42 |
|
|
2016
Q2 | $807K | Sell |
9,675
-485
| -5% | -$43K | 0.3% | 43 |
|
|
2016
Q1 | $933K | Buy |
10,160
+473
| +5% | +$42.7K | 0.35% | 36 |
|
|
2015
Q4 | $980K | Buy |
9,687
+3,275
| +51% | +$341K | 0.37% | 29 |
|
|
2015
Q3 | $629K | Buy |
6,412
+552
| +9% | +$61.3K | 0.27% | 35 |
|
|
2015
Q2 | $648K | Buy |
5,860
+103
| +2% | +$11.3K | 0.26% | 31 |
|
|
2015
Q1 | $565K | Sell |
5,757
-526
| -8% | -$53.4K | 0.23% | 33 |
|
|
2014
Q4 | $592K | Sell |
6,283
-662
| -10% | -$68.5K | 0.25% | 35 |
|
|
2014
Q3 | $739K | Sell |
6,945
-1,536
| -18% | -$150K | 0.35% | 27 |
|
|
2014
Q2 | $703K | Sell |
8,481
-1,216
| -13% | -$94.7K | 0.32% | 31 |
|
|
2014
Q1 | $687K | Buy |
9,697
+519
| +6% | +$40.7K | 0.33% | 30 |
|
|
2013
Q4 | $689K | Buy |
+9,178
| New | +$639K | 0.31% | 29 |
|
Other funds holding GILD
Waldron Private Wealth's GILD Position: Q1 2025 in Review
Waldron Private Wealth sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 10,229 shares — an estimated $945K sold.
Waldron Private Wealth first reported a position in GILD in Q4 2013 and held it in 45 quarters. The position peaked at $980K in Q4 2015. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.
- Waldron Private Wealth reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
- Waldron Private Wealth sold 10,229 Gilead Sciences shares in Q1 2025, an estimated $945K.
- Waldron Private Wealth first reported a position in Gilead Sciences in Q4 2013 and held it in 45 quarters.
- Waldron Private Wealth's Gilead Sciences position peaked at $980K in Q4 2015.
- 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.
Based on Waldron Private Wealth's 13F filing for Q1 2025, filed 8 May 2025.